The majority of penile carcinoma is squamous cell carcinoma. Although uncommon in the United States, it represents a larger proportion of cancers in the underdeveloped world. Invasive squamous cell carcinoma may arise from precursor lesions or de novo, and has been associated with lack of circumcision and HPV infection. Early diagnosis is imperative as lymphatic spread is associated with a poor prognosis. Radical surgical treatment is no longer the mainstay, and penile sparing treatments now are often used, including Mohs micrographic surgery. Therapeutic decisions should be made with regard to the size and location of the tumor, as well as the functional desires of the patient. It is critical for the dermatologist to be familiar with the evaluation, grading/staging, and treatment advances of penile squamous cell carcinoma. Herein, we present a review of the literature regarding penile squamous cell carcinoma, as well as a case report of invasive squamous cell carcinoma treated with Mohs micrographic surgery.
INTRODUCTION
Penile cancer is a rare diagnosis in the United States and other developed nations. In the United States in 2015, the American Cancer Society predicted 1,820 new cases with 310 penile cancer deaths. 1 However, the disease is more common in developing countries, where it may represent up to 10% of cancers in males. 2, 3, 4 The majority of penile cancer is squamous cell carcinoma (SCC). 5 The pathogenesis of penile cancer is not entirely known.
SCC may evolve from penile intraepithelial neoplasia (PIN) or arise de novo. 4 Penile SCC has been associated with high-risk HPV infections, most commonly strains 16 and 18. The mechanism through which HPV leads to penile cancer is most likely mediated through viral oncogenes E6 and E7, which are actively transcribed by HPV-infected cells. Viral oncogene E6 targets p53 and viral oncogene E7 targets RB1; both p53 and RB1 are tumor suppressor genes, which are negative regulators of cell proliferation. When these genes are transformed, this may lead to unchecked proliferation and subsequent development of malignancy. 3 HPV-DNA has been found in only 22-72% of penile SCC, but has been identified in the vast majority of PIN (70-100%). 3 This discordance between the presence of HPV-DNA in SCC versus PIN suggests an HPV independent and dependent etiology for the development of SCC. 4 The prevalence of genital HPV-DNA in men is 1.3% to 72.9%, with a mean of >20% reported by most studies. 6 In several cohort studies, it is estimated that most HPV infections in men clear in less than 12 months, with a median of 5.9 to 7.5 months. 7, 8 Increasing age and fewer numbers of female partners are positively correlated with a greater probability of clearing an HPV infection. 8 The development of the quadrivalent HPV vaccine to high-risk strains 6, 11, 16, and 18, has been shown to significantly reduce HPV-associated genital disease in men, including genital warts, with an efficacy of 89.4%. 9 The use of the HPV vaccine in males has the potential to significantly reduce the incidence of penile cancer, among other disfiguring genital lesions such as condylomas and genital warts.
Penile SCC occurs almost exclusively in uncircumcised men. 3 Neonatal circumcision is implicated as strongly protective 4 Phimosis, the inability to retract the foreskin over the glans, has been found in 25-60% of patients with penile cancer. 3, 4 It is associated with an increased incidence of infection as well as dysplastic changes of the preputial sac. 12 Further, uncircumcised men have been found to be at an increased risk of HPV infection when compared to their circumcised counterparts. 13 Additional risk factors associated with the development of penile SCC include smoking, HIV infection, poor genital hygiene, previous injury to the penis, chronic balanitis, lichen sclerosis et atrophicus, and psoralen plus ultraviolet A treatment to the area. 3, 4, 14 Penile SCC most commonly presents between the ages of 50 and 70 years. 3 The majority of lesions are found on the glans (48%), followed by the prepuce (21%), both glans and prepuce (15%), coronal sulcus (6%), and shaft (<2%). 3 Clinical presentation is variable.
It may present as a small area of induration and erythema or a large ulcerating and infiltrative lesion. As the disease progresses, there may be associated itching, bleeding, discharge, foul odor, and pain. course, first to the superficial and deep inguinal nodes, followed by the pelvic, and then periaortic nodes. 15 Distant metastases are generally uncommon (1-10%) and occur late in the disease.
3,15
Differential diagnostic considerations of penile SCC include premalignant and malignant lesions, infections, and inflammatory conditions. Neoplastic lesions such as erythroplasia of Queyrat, Bowen's disease or Bowenoid papulosis should be considered. 4 Condyloma acuminata may resemble SCC, especially the verrucous variant. Ulceration and lymphadenopathy may raise concern for the chancre of a primary syphilis infection or the chancroid of Haemophilus ducreyi. Additionally, the psoriatic scales and plaques of genital psoriasis and violaceous lesions of lichen planus may appear clinically similar to SCC.
14 Penile SCC can be divided into several subtypes. The most common subtypes include usual SCC (48-65%), basaloid carcinoma (4-10%), warty carcinoma (7-10%), verrucous carcinoma (3-8%), papillary carcinoma (5-15%), and mixed carcinomas (9-10%). 16 Each subtype has distinct histologic features. Histopathologic analysis is used to grade the tumor, which is then assigned on a spectrum based on cellular differentiation (Chart 1). 14, 16, 17 Staging is performed using the TNM penile cancer system developed by the American Joint Committee on Cancer (Chart 2). 17 Staging is based on depth of tumor invasion, nodal involvement, and distant metastases (Chart 3). Tumor invades other adjacent structures * Note: Broad pushing penetration (invasion) is permitted; destructive invasion is against this diagnosis. 
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No distant metastasis M1 Distant metastasis* *Note: Lymph node metastasis outside of the true pelvis in addition to visceral or bone sites. excision using 2 cm margins has been traditionally used; however, smaller 5 to 10 mm margins have shown low recurrence rates. 14 Mohs micrographic surgery (MMS) is becoming increasingly popular and has the ability to provide superior aesthetic results with preservation of normal surrounding tissue. 15, 18, 19 A great advantage of using MMS is removal of the tumor with complete visualization to ensure negative margins. 18, 19 For penile SCC, MMS is most successful in smaller tumors with lower grade. 18 If urethral involvement is present, MMS should be discouraged. 19 Patients with tumors staged II and above are usually not candidates for penile sparing therapy due to larger tumor size and further depth of invasion. 14, 15 Partial or total penectomy should be considered in these patients. Concern should be taken for preservation of urination and sexual function. 20 Radiation and chemotherapy could be used as adjuvant therapy or in cases of palliation.
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Evaluation of lymphatic spread is critical and guidelines are still emerging. 5 About 28-64% of patients will present with palpable inguinal nodes. 21 However, of these, 47-85% will have metastatic disease, with the remainder of nodal enlargement secondary to inflammation. 4, 21 Even in patients without palpable nodes, an estimated 25% will still have micrometastatic disease. 14 Inguinal lymph node dissection is a diagnostic and potentially curative procedure. 14, 22 However, due to potential complications, it is preferred to only perform this procedure in patients at a high risk for metastasis. 15, 22 Techniques such as MRI, PET scan, fine needle aspiration, and dynamic sentinel node biopsy may precede an inguinal lymph node dissection. 15 Minimally invasive techniques such as laparoscopic or robotic-assisted inguinal lymphadenectomy are evolving. 22, 23 A multidisciplinary treatment team involving medical oncology, radiation oncology, urology, and psychiatry in addition to dermatology may be warranted. 15, 24 Prognosis is good for localized disease. The most important prognostic factor is the extent of nodal metastasis. 15, 21 The 5-year cancer specific survival of a primary SCC with no inguinal metastasis is 85-100%, one positive node is 79 to 89%, bilateral or multiple nodal metastasis is 17 to 60%, and metastasis to pelvic nodes is 0 to 17%. 21 Prognosis with extranodal metastasis is poor. Tis  N0  M0  Ta  N0  M0  Stage I  T1a  N0  M0  Stage II  T1b  N0  M0  T2  N0  M0  T3  N0  M0  Stage IIIa  T1-3  N1  M0  Stage IIIb  T1- The consultant urologist concluded that the patient's inguinal hernias limited nodal evaluation and recommended hernia repair prior to further assessment. The patient was seen by general surgery for evaluation, however he refused further interventions.
The patient was followed for over one year with no evidence of recurrence of the lesion and no functional concerns.
Squamous cell carcinoma of the penis is a rare diagnosis.
Therapeutic decisions should be made with regard to the size and location of the tumor, as well as with consideration to the functional desires of the patient. Mohs micrographic surgery is an excellent alternative for patients with tumors of low grade and stage.q
